TickerFacts.

Absci Corp (ABSI): Net Income

Annual figures by period end, from SEC filings.

-$115.18M
Year ended 2025-12-31
-$121.08M
Trailing 12 months to 2026-06-30
2020-12-31: -$14.35M2021-12-31: -$100.96M2022-12-31: -$104.90M2023-12-31: -$110.57M2024-12-31: -$103.11M2025-12-31: -$115.18M-$115.18M
2020-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$115.18Mn/m2026-03-24, From 2025-01-01
2024-12-31-$103.11Mn/m2026-03-24, From 2024-01-01
2023-12-31-$110.57Mn/m2025-03-18, From 2023-01-01
2022-12-31-$104.90Mn/m2024-03-21, From 2022-01-01
2021-12-31-$100.96Mn/m2023-03-30, From 2021-01-01
2020-12-31-$14.35Mn/a2022-03-22, From 2020-01-01

Net Income at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Absci Corp (ABSI)2025-12-31-$115.18Mn/m
iSpecimen Inc. (ISPC)2025-12-31-$10.49Mn/m
OneMedNet Corp (ONMD)2025-12-31-$2.80Mn/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$14.91Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$12.43Mn/m
OmniAb, Inc. (OABI)2025-12-31-$64.78Mn/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31-$548.8Kn/m
MaxCyte, Inc. (MXCT)2025-12-31-$44.63Mn/m
NRC Health (NRC)2025-12-31$11.60M-53.2%

Compare ABSI, ISPC, ONMD, BIAF side by side · Screen every company in Services-Commercial Physical & Biological Research ↗